
Higher Buprenorphine Doses Keep Patients in Treatment Longer
A groundbreaking study of 5,000 patients in Philadelphia shows that higher doses of buprenorphine help people with opioid use disorder stay in treatment twice as long. The FDA just updated its guidelines to support these findings, opening doors to better care.

